Blood Collection Market (2010 - 2021)

Blood Collection Market Research Report By Type (Vacutainer, Syringes, Blood Collection Tubes, Blood Bags), By Method (Manual Blood Collection, Automated Blood Collection, Capillary Blood Collection), By End Use (Hospitals, Diagnostic Laboratories, Blood Banks, Home Care), By Application (Transfusion, Diagnostic Testing, Research) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period
2010-2021
CAGR
6.13%
2010 Market Size
8.84 USD Billion
2021 Market Size
9.33 USD Billion
Healthcare ● Updated August 2026 Report ID: MRFR/HC/5548-HCR | Pages: 200 | Author: Rahul Gotadki, Nidhi Mandole
  1. 1 Market Overview |
    1. 1.1 Study Assumptions & Market Definition |
    2. 1.2 Scope of the Study |
    3. 1.3 Research Methodology
  2. 2 Market Summary & Key Takeaways |
    1. 2.1 Key Findings by Product |
    2. 2.2 Key Findings by Collection Method & Application |
    3. 2.3 Key Findings by Geography
  3. 3 Market Dynamics |
    1. 3.1 Market Drivers Analysis | |
      1. 3.1.1 Chronic Disease Burden and Diagnostic Test Volume Growth | |
      2. 3.1.2 Sharps-Safety Regulation and Device Conversion | |
      3. 3.1.3 Laboratory Automation Amid Phlebotomist Shortages | |
      4. 3.1.4 Blood-Banking Network Expansion in Emerging Economies | |
      5. 3.1.5 Decentralized and Home-Based Specimen Collection |
    2. 3.2 Market Restraints Analysis | |
      1. 3.2.1 Consumable Commoditization and Tender Price Erosion | |
      2. 3.2.2 Reimbursement Compression on Routine Testing | |
      3. 3.2.3 EU MDR and UDI Compliance Cost Burden | |
      4. 3.2.4 Polymer Supply and Sterilization Capacity Constraints | |
      5. 3.2.5 Substitution from Sampling Miniaturization |
    3. 3.3 Market Opportunity Analysis | |
      1. 3.3.1 Safety Conversion in Asia-Pacific and Latin America | |
      2. 3.3.2 Home and Retail Specimen Collection Channels | |
      3. 3.3.3 Automation-Ready Consumable Ecosystems | |
      4. 3.3.4 Donor Data and Managed-Service Models | |
      5. 3.3.5 Sustainable Materials and Sharps Circularity |
    4. 3.4 Industry Value Chain Analysis |
    5. 3.5 Porter's Five Forces Analysis
  4. 4 Global Blood Collection Market Size & Forecast (2021–2035) |
    1. 4.1 Historical Market Size (2021–2025) |
    2. 4.2 Current & Forecast Market Size (2026–2035) |
    3. 4.3 Market Size by Revenue (USD Billion) |
    4. 4.4 Year-over-Year Growth Analysis
  5. 5 Segmentation Analysis |
    1. 5.1 By Product | |
      1. 5.1.1 Needles & Syringes | |
      2. 5.1.2 Safety Needles | |
      3. 5.1.3 Tubes | |
      4. 5.1.4 Blood Bags | |
      5. 5.1.5 Lancets | |
      6. 5.1.6 Other Products |
    2. 5.2 By Collection Method | |
      1. 5.2.1 Manual | |
      2. 5.2.2 Automated |
    3. 5.3 By Application | |
      1. 5.3.1 Diagnostics | |
      2. 5.3.2 Therapeutics / Transfusion |
    4. 5.4 By End User | |
      1. 5.4.1 Hospitals & Diagnostic Centers | |
      2. 5.4.2 Blood Banks | |
      3. 5.4.3 Point-of-Care & Home-Care Settings | |
      4. 5.4.4 Research & Academic Laboratories | |
      5. 5.4.5 Other End Users
  6. 6 Regional Analysis |
    1. 6.1 North America | |
      1. 6.1.1 US | |
      2. 6.1.2 Canada | |
      3. 6.1.3 Mexico |
    2. 6.2 Europe | |
      1. 6.2.1 Germany | |
      2. 6.2.2 UK | |
      3. 6.2.3 France | |
      4. 6.2.4 Italy | |
      5. 6.2.5 Spain | |
      6. 6.2.6 Nordic Countries | |
      7. 6.2.7 Russia | |
      8. 6.2.8 Rest of Europe |
    3. 6.3 Asia-Pacific | |
      1. 6.3.1 China | |
      2. 6.3.2 India | |
      3. 6.3.3 Japan | |
      4. 6.3.4 South Korea | |
      5. 6.3.5 ASEAN | |
      6. 6.3.6 Rest of Asia-Pacific |
    4. 6.4 South America | |
      1. 6.4.1 Brazil | |
      2. 6.4.2 Argentina | |
      3. 6.4.3 Rest of South America |
    5. 6.5 Middle East & Africa | |
      1. 6.5.1 Saudi Arabia | |
      2. 6.5.2 UAE | |
      3. 6.5.3 South Africa | |
      4. 6.5.4 Egypt | |
      5. 6.5.5 Rest of Middle East & Africa
  7. 7 Competitive Landscape |
    1. 7.1 Market Share Analysis (2026) |
    2. 7.2 Competitive Benchmarking Matrix |
    3. 7.3 Company Profiles | |
      1. 7.3.1 Becton, Dickinson and Company | |
      2. 7.3.2 Terumo Corporation | |
      3. 7.3.3 Fresenius Kabi | |
      4. 7.3.4 Grifols S.A. | |
      5. 7.3.5 Greiner Bio-One | |
      6. 7.3.6 Nipro Corporation | |
      7. 7.3.7 Sarstedt AG & Co. KG | |
      8. 7.3.8 Haemonetics Corporation | |
      9. 7.3.9 Cardinal Health | |
      10. 7.3.10 Macopharma | |
      11. 7.3.11 Retractable Technologies | |
      12. 7.3.12 Improve Medical Instruments
  8. 8 Future Outlook & Strategic Recommendations (2026–2035) |
    1. 8.1 Near-Term Outlook (2026–2028) |
    2. 8.2 Medium-Term Outlook (2029–2031) |
    3. 8.3 Long-Term Outlook (2032–2035)
  9. 9 Recent Developments & News
  10. 10 Frequently Asked Questions (FAQs)
  11. 11 Report Scope & Methodology |
    1. 11.1 Study Period & Base Year |
    2. 11.2 Data Sources & Citations |
    3. 11.3 Abbreviations
  12. 12 LIST OF TABLES |
  13. TABLE 1 Global Blood Collection Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
  14. TABLE 2 Global Blood Collection Market – Year-over-Year Growth Analysis, 2021–2035 |
  15. TABLE 3 Global Blood Collection Market – Driver Impact Analysis, 2026–2035 |
  16. TABLE 4 Global Blood Collection Market – Restraint Impact Analysis, 2026–2035 |
  17. TABLE 5 Global Blood Collection Market Size, by Product, 2021–2035 (USD Billion) |
  18. TABLE 6 Global Blood Collection Market Size, by Collection Method, 2021–2035 (USD Billion) |
  19. TABLE 7 Global Blood Collection Market Size, by Application, 2021–2035 (USD Billion) |
  20. TABLE 8 Global Blood Collection Market Size, by End User, 2021–2035 (USD Billion) |
  21. TABLE 9 Global Blood Collection Market Size, by Region, 2021–2035 (USD Billion) |
  22. TABLE 10 North America Blood Collection Market Size, by Country, 2021–2035 (USD Billion) |
  23. TABLE 11 Europe Blood Collection Market Size, by Country, 2021–2035 (USD Billion) |
  24. TABLE 12 Asia-Pacific Blood Collection Market Size, by Country, 2021–2035 (USD Billion) |
  25. TABLE 13 South America Blood Collection Market Size, by Country, 2021–2035 (USD Billion) |
  26. TABLE 14 Middle East & Africa Blood Collection Market Size, by Country, 2021–2035 (USD Billion) |
  27. TABLE 15 North America Blood Collection Market Size, by Product, 2021–2035 (USD Billion) |
  28. TABLE 16 North America Blood Collection Market Size, by Collection Method, 2021–2035 (USD Billion) |
  29. TABLE 17 North America Blood Collection Market Size, by Application, 2021–2035 (USD Billion) |
  30. TABLE 18 North America Blood Collection Market Size, by End User, 2021–2035 (USD Billion) |
  31. TABLE 19 Europe Blood Collection Market Size, by Product, 2021–2035 (USD Billion) |
  32. TABLE 20 Europe Blood Collection Market Size, by Collection Method, 2021–2035 (USD Billion) |
  33. TABLE 21 Europe Blood Collection Market Size, by Application, 2021–2035 (USD Billion) |
  34. TABLE 22 Europe Blood Collection Market Size, by End User, 2021–2035 (USD Billion) |
  35. TABLE 23 Asia-Pacific Blood Collection Market Size, by Product, 2021–2035 (USD Billion) |
  36. TABLE 24 Asia-Pacific Blood Collection Market Size, by Collection Method, 2021–2035 (USD Billion) |
  37. TABLE 25 Asia-Pacific Blood Collection Market Size, by Application, 2021–2035 (USD Billion) |
  38. TABLE 26 Asia-Pacific Blood Collection Market Size, by End User, 2021–2035 (USD Billion) |
  39. TABLE 27 South America Blood Collection Market Size, by Product, 2021–2035 (USD Billion) |
  40. TABLE 28 South America Blood Collection Market Size, by End User, 2021–2035 (USD Billion) |
  41. TABLE 29 Middle East & Africa Blood Collection Market Size, by Product, 2021–2035 (USD Billion) |
  42. TABLE 30 Middle East & Africa Blood Collection Market Size, by End User, 2021–2035 (USD Billion) |
  43. TABLE 31 US Blood Collection Market Size, by Product and End User, 2021–2035 (USD Billion) |
  44. TABLE 32 China Blood Collection Market Size, by Product and End User, 2021–2035 (USD Billion) |
  45. TABLE 33 India Blood Collection Market Size, by Product and End User, 2021–2035 (USD Billion) |
  46. TABLE 34 Germany Blood Collection Market Size, by Product and End User, 2021–2035 (USD Billion) |
  47. TABLE 35 Competitive Benchmarking Matrix – Global Blood Collection Market, 2026 |
  48. TABLE 36 Company Profiles – Key Players, Global Blood Collection Market |
  49. TABLE 37 Recent Developments & Strategic Announcements, 2023–2025 |
  50. TABLE 38 Report Scope & Methodology Summary |
  51. TABLE 39 Detailed Sources and Citations Index
  52. 13 LIST OF FIGURES |
  53. FIGURE 1 Global Blood Collection Market – Market Dynamics Snapshot (Drivers, Restraints, Opportunities) |
  54. FIGURE 2 Industry Value Chain Analysis – Blood Collection Market |
  55. FIGURE 3 Porter's Five Forces Analysis – Blood Collection Market |
  56. FIGURE 4 Global Blood Collection Market Size Trend, 2021–2035 (USD Billion) |
  57. FIGURE 5 Year-over-Year Growth Rate Trend, 2022–2035 (%) |
  58. FIGURE 6 Market Share by Product, 2025 vs 2035 (%) |
  59. FIGURE 7 Market Share by Collection Method, 2025 vs 2035 (%) |
  60. FIGURE 8 Market Share by Application, 2025 vs 2035 (%) |
  61. FIGURE 9 Market Share by End User, 2025 vs 2035 (%) |
  62. FIGURE 10 Regional Revenue Share Distribution, 2025 (%) |
  63. FIGURE 11 Regional CAGR Comparison, 2026–2035 (%) |
  64. FIGURE 12 Country-Level Growth Heat Map, 2026–2035 |
  65. FIGURE 13 Competitive Landscape – Estimated Revenue Share Ranges, 2026 |
  66. FIGURE 14 Competitive Positioning Quadrant – Scale vs Innovation Intensity |
  67. FIGURE 15 Safety Device Conversion Penetration by Region, 2025
Share::
Request Free Sample

Segmentation Quick Reference

DimensionSub-SegmentsDominant SegmentFastest Growing Segment
By ProductNeedles & Syringes, Safety Needles, Tubes, Blood Bags, Lancets, Other ProductsNeedles & SyringesTubes
By Collection MethodManual, AutomatedManualAutomated
By ApplicationDiagnostics, Therapeutics / TransfusionDiagnosticsTherapeutics / Transfusion
By End UserHospitals & Diagnostic Centers, Blood Banks, Point-of-Care & Home-Care Settings, Research & Academic Laboratories, Other End UsersHospitals & Diagnostic CentersPoint-of-Care & Home-Care Settings
By GeographyNorth America, Europe, Asia-Pacific, South America, Middle East & AfricaNorth AmericaAsia-Pacific

 

Market Segmentation Overview

By Product

Sub-SegmentKey Trend
Needles & SyringesSteady volume base; gradual mix migration toward engineered safety variants
Safety NeedlesRegulatory-driven conversion sustains ASP premium in mature markets
TubesAdditive specialization for molecular, coagulation, and liquid-biopsy workflows
Blood BagsDemand tracks national donation programs and transfusion reserve policy
LancetsGrowth tied to point-of-care testing and self-monitoring adoption
Other ProductsTourniquets, holders, and transfer devices shifting to single-patient-use formats

 

Product strategy divides cleanly between defending commodity share and capturing specialty growth. Tubes deliver the most attractive economics because assay-specific additives resist substitution once a laboratory validates them.

By Collection Method

Sub-SegmentKey Trend
ManualRemains default below threshold daily draw volumes; declining revenue share
AutomatedApheresis and pre-analytical robotics absorb labor scarcity; strongest growth profile

 

Automation adoption follows labor economics more than clinical preference. Sites with chronic staffing gaps convert first, which explains faster uptake in North America, Western Europe, and Japan than in high-volume, low-cost geographies.

By Application

Sub-SegmentKey Trend
DiagnosticsRecurring chronic-disease panels create annuity-like consumable demand
Therapeutics / TransfusionPlasma-derived therapy demand pulls apheresis consumable volume upward

 

Diagnostics supplies the scale, transfusion supplies the growth differential. Source plasma collection in particular has outpaced whole-blood transfusion demand for several consecutive years.

By End User

Sub-SegmentKey Trend
Hospitals & Diagnostic CentersOutreach phlebotomy expands faster than inpatient draw volume
Blood BanksDonor recruitment pressure drives investment in session-efficiency technology
Point-of-Care & Home-Care SettingsPayer-funded home draws and direct-to-consumer testing scale rapidly
Research & Academic LaboratoriesDecentralized clinical trials require shipping-validated collection kits
Other End UsersOccupational health, insurance underwriting, and military screening programs

 

End-user mix is migrating outward from the hospital. Suppliers built around bulk institutional SKUs will need distinct packaging, stabilization, and fulfilment capabilities to serve decentralized channels profitably.

By Region

Sub-SegmentKey Trend
North AmericaSafety compliance and pre-analytical automation dominate spend
EuropeCentralized tendering plus sustainability scoring reshapes supplier selection
Asia-PacificCapacity buildout and domestic-content procurement rules drive localization
South AmericaPublic hemocentro modernization anchors demand; currency risk shapes pricing
Middle East & AfricaGulf premium procurement contrasts with donor-agency funded infrastructure elsewhere

 

Regional strategy cannot be uniform. Winning in Asia-Pacific requires local manufacturing and price discipline; winning in Europe requires regulatory dossier depth and environmental documentation.

 

 

 

 

 

 

 

 

 

 

 

Share::
Request Free Sample
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.